Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Degarelix Acetate Prior to Radiation Therapy

NCT01731912 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT01731912
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01731912 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Degarelix Acetate Prior to Radiation Therapy
Lead sponsor
University of Washington
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2013
Completion date
September 30, 2016
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate adenocarcinoma, stage iia prostate cancer, stage iib prostate cancer, stage iii prostate cancer, stage iv prostate cancer